Related Experiment Video
Updated: Feb 18, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Management of severe asymptomatic aortic stenosis: An updated overview
Christophe Tribouilloy1, Yohann Bohbot1, Dan Rusinaru1
1Department of Cardiology, Amiens University Hospital, 80054 Amiens, France; UR UPJV 7517, Jules-Verne University of Picardie, 80054 Amiens, France.
Insights
Aortic stenosis management is complex, especially for asymptomatic patients. Early intervention may benefit selected individuals, but careful risk assessment and shared decision-making are crucial for optimal outcomes.
Area of Science:
- Cardiology
- Valvular Heart Disease
- Geriatric Cardiology
Background:
- Aortic stenosis is the most common valvular heart disease in older adults.
- No medical treatments can halt its progression; aortic valve replacement is the only cure.
- Managing asymptomatic patients presents challenges due to risks of sudden death versus procedural complications.
Purpose of the Study:
- To review the current strategies for managing aortic stenosis, particularly in asymptomatic patients.
- To highlight the importance of functional assessment and accurate severity evaluation.
- To discuss modern risk stratification and the role of early intervention.
Main Methods:
- Review of current guidelines and literature on aortic stenosis management.
- Emphasis on echocardiography for severity assessment.
- Integration of functional testing (exercise testing) and risk stratification markers.
Main Results:
- Functional assessment identifies "falsely asymptomatic" patients who benefit from timely intervention.
- Early aortic valve replacement shows mixed results regarding survival benefit but reduces hospitalizations.
- Current guidelines recommend intervention for symptomatic patients or those with reduced ejection fraction, with selective early intervention for low-risk asymptomatic patients.
Conclusions:
- Shared decision-making within a multidisciplinary heart valve team is essential.
- Consideration of patient preferences, comorbidities, and lifestyle is critical.
- Close follow-up with regular testing optimizes timing and outcomes for aortic stenosis patients.
Abstract:
Aortic stenosis is the most frequent valvular heart disease in industrialized countries, affecting about 10% of individuals aged>75years, with 2-4% presenting severe disease; nearly half of them are asymptomatic. No medical therapy halts aortic stenosis progression, and aortic valve replacement remains the only curative option. Managing asymptomatic patients is challenging because of a persistent risk of sudden death, and the potential for irreversible myocardial damage if intervention is delayed, but also because aortic valve replacement carries procedural risks and long-term prosthesis-related complications. Functional assessment, especially exercise testing, is essential as it can identify a substantial proportion of "falsely asymptomatic" patients who will benefit from timely aortic valve replacement. Accurate assessment of aortic stenosis severity is crucial, with echocardiography as the cornerstone, although additional imaging modalities may be required in selected cases. Modern risk stratification integrates markers of subclinical myocardial dysfunction, haemodynamic compromise and procedural risk. Although observational studies and randomized trials suggest that early aortic valve replacement may reduce adverse events in selected low-risk patients, results are heterogeneous and methodological concerns remain. Meta-analyses have shown reductions in unplanned hospitalizations but no clear survival benefit with early intervention. Current guidelines recommend aortic valve replacement for classical indications, such as symptom onset or reduced ejection fraction, and suggest early aortic valve replacement only in carefully selected asymptomatic patients with low procedural risk. Shared decision-making within a multidisciplinary heart valve team remains essential, taking into account patient preferences, co-morbidities, life expectancy and lifestyle. Close follow-up with regular echocardiography and functional testing is critical to optimize timing and outcomes.
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Mitral Stenosis IV: Nursing Management
Aneurysm III: Interprofessional Care
Aortic Regurgitation I: Introduction
Atherosclerosis III: Management

